Leaflet FLUDARA 50mg lyophilisate for solution for injection / infusion
Indicated for: cancer
Route of administration: injectable / infusion
Substance: fludarabine (antimetabolite antineoplastic)
ATC: L01BB05 (Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Fludarabine is a medication used to treat certain types of blood cancer, especially chronic lymphocytic leukemia. This medicine works by inhibiting the growth and multiplication of cancer cells, helping to control the disease and prolong patient survival. Fludarabine is often used when other treatments have not been successful or are not suitable for the patient.
Fludarabine is usually administered by intravenous infusion under the strict supervision of medical staff. The dose and duration of treatment are determined by the doctor based on the patient's general condition, type, and stage of the disease. It is essential to follow the treatment as directed to achieve the best results.
Side effects of fludarabine may include a decrease in blood cell counts, which increases the risk of infections, bleeding, or severe fatigue. Other reactions may include nausea, vomiting, diarrhea, or skin rashes. In rare cases, severe reactions such as nervous system damage or serious allergic reactions may occur.
Fludarabine is a powerful medication, and its administration requires careful monitoring and regular tests. Inform your doctor about any unusual symptoms or other medications you are taking. Following medical recommendations is essential for the safety and effectiveness of the treatment.
General data about FLUDARA 50mg
- Substance: fludarabine
- Date of last drug list: 01-07-2017
- Commercial code: W56211001
- Concentration: 50mg
- Pharmaceutical form: lyophilisate for solution for injection / infusion
- Quantity: 5
- Product type: original
- Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.
Pharmaceutical forms available for fludarabine
Concentrations available for fludarabine
- 10mg
- 25mg/ml
- 50mg